Literature DB >> 11083787

Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection.

E T Harvill1, A Preston, P A Cotter, A G Allen, D J Maskell, J F Miller.   

Abstract

Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica are closely related subspecies that cause respiratory tract infections in humans and other mammals and express many similar virulence factors. Their lipopolysaccharide (LPS) molecules differ, containing either a complex trisaccharide (B. pertussis), a trisaccharide plus an O-antigen-like repeat (B. bronchiseptica), or an altered trisaccharide plus an O-antigen-like repeat (B. parapertussis). Deletion of the wlb locus results in the loss of membrane-distal polysaccharide domains in the three subspecies of bordetellae, leaving LPS molecules consisting of lipid A and core oligosaccharide. We have used wlb deletion (Deltawlb) mutants to investigate the roles of distal LPS structures in respiratory tract infection by bordetellae. Each mutant was defective compared to its parent strain in colonization of the respiratory tracts of BALB/c mice, but the location in the respiratory tract and the time point at which defects were observed differed significantly. Although the Deltawlb mutants were much more sensitive to complement-mediated killing in vitro, they displayed similar defects in respiratory tract colonization in C5(-/-) mice compared with wild-type (wt) mice, indicating that increased sensitivity to complement-mediated lysis is not sufficient to explain the in vivo defects. B. pertussis and B. parapertussis Deltawlb mutants were also defective compared to wt strains in colonization of SCID-beige mice, indicating that the defects were not limited to interactions with adaptive immunity. Interestingly, the B. bronchiseptica Deltawlb strain was defective, compared to the wt strain, in colonization of the respiratory tracts of BALB/c mice beginning 1 week postinoculation but did not differ from the wt strain in its ability to colonize the respiratory tracts of B-cell- and T-cell-deficient mice, suggesting that wlb-dependent LPS modifications in B. bronchiseptica modulate interactions with adaptive immunity. These data show that biosynthesis of a full-length LPS molecule by these three bordetellae is essential for the expression of full virulence for mice. In addition, the data indicate that the different distal structures modifying the LPS molecules on these three closely related subspecies serve different purposes in respiratory tract infection, highlighting the diversity of functions attributable to LPS of gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083787      PMCID: PMC97772          DOI: 10.1128/IAI.68.12.6720-6728.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica.

Authors:  M H Yuk; E T Harvill; J F Miller
Journal:  Mol Microbiol       Date:  1998-06       Impact factor: 3.501

2.  Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection.

Authors:  E T Harvill; P A Cotter; J F Miller
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

Authors:  C M Tsai; C E Frasch
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

4.  Modulation of host immune responses, induction of apoptosis and inhibition of NF-kappaB activation by the Bordetella type III secretion system.

Authors:  M H Yuk; E T Harvill; P A Cotter; J F Miller
Journal:  Mol Microbiol       Date:  2000-03       Impact factor: 3.501

5.  Probing the function of Bordetella bronchiseptica adenylate cyclase toxin by manipulating host immunity.

Authors:  E T Harvill; P A Cotter; M H Yuk; J F Miller
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

6.  Molecular and functional analysis of the lipopolysaccharide biosynthesis locus wlb from Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica.

Authors:  A G Allen; R M Thomas; J T Cadisch; D J Maskell
Journal:  Mol Microbiol       Date:  1998-07       Impact factor: 3.501

7.  Genetic defect in secretion of complement C5 in mice.

Authors:  Y M Ooi; H R Colten
Journal:  Nature       Date:  1979-11-08       Impact factor: 49.962

8.  Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels.

Authors:  P J Hitchcock; T M Brown
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

9.  Chromosomal location of the genes encoding complement components C5 and factor H in the mouse.

Authors:  P D'Eustachio; T Kristensen; R A Wetsel; R Riblet; B A Taylor; B F Tack
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

10.  Genetic basis for lipopolysaccharide O-antigen biosynthesis in bordetellae.

Authors:  A Preston; A G Allen; J Cadisch; R Thomas; K Stevens; C M Churcher; K L Badcock; J Parkhill; B Barrell; D J Maskell
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

View more
  58 in total

1.  Pneumonia due to Bordetella bronchiseptica in a cystic fibrosis patient: 16S rRNA sequencing for diagnosis confirmation.

Authors:  Frédéric Wallet; Thierry Perez; Sylvie Armand; Benoit Wallaert; René J Courcol
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection.

Authors:  Mylisa R Pilione; Elizabeth J Pishko; Andrew Preston; Duncan J Maskell; Eric T Harvill
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

3.  Molecular structure of WlbB, a bacterial N-acetyltransferase involved in the biosynthesis of 2,3-diacetamido-2,3-dideoxy-D-mannuronic acid .

Authors:  James B Thoden; Hazel M Holden
Journal:  Biochemistry       Date:  2010-06-08       Impact factor: 3.162

4.  Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity.

Authors:  Daniel N Wolfe; Girish S Kirimanjeswara; Eric T Harvill
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

5.  The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance.

Authors:  Mylisa R Pilione; Eric T Harvill
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

6.  Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.

Authors:  Xuqing Zhang; Sara E Hester; Mary J Kennett; Alexia T Karanikas; Liron Bendor; David E Place; Eric T Harvill
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

7.  The Bordetella pertussis Bps polysaccharide enhances lung colonization by conferring protection from complement-mediated killing.

Authors:  Tridib Ganguly; John B Johnson; Nancy D Kock; Griffith D Parks; Rajendar Deora
Journal:  Cell Microbiol       Date:  2014-02-13       Impact factor: 3.715

8.  Respiratory disease in kennelled dogs: serological responses to Bordetella bronchiseptica lipopolysaccharide do not correlate with bacterial isolation or clinical respiratory symptoms.

Authors:  Victoria J Chalker; Crista Toomey; Shaun Opperman; Harriet W Brooks; Michael A Ibuoye; Joe Brownlie; Andrew N Rycroft
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

9.  Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract.

Authors:  Kelly D Elder; Eric T Harvill
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

10.  Cavitary pneumonia in an AIDS patient caused by an unusual Bordetella bronchiseptica variant producing reduced amounts of pertactin and other major antigens.

Authors:  Benito Lorenzo-Pajuelo; José Luis Villanueva; Juan Rodríguez-Cuesta; Nuria Vergara-Irigaray; Máximo Bernabeu-Wittel; Andrés Garcia-Curiel; Guillermo Martínez de Tejada
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.